Major PBM Looks to Stem Gilead Sciences' (GILD) Hepatitis C Profits
Go back to Major PBM Looks to Stem Gilead Sciences' (GILD) Hepatitis C Profits| Express Scripts (NASDAQ: ESRX) | Delayed: 92.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.33 | 52 Week High | $89.00 | |||
| Open | $0.01 | 52 Week Low | $64.46 | |||
| Day High | $92.33 | P/E | 39.97 | |||
| Day Low | $92.33 | EPS | $2.31 | |||
| Volume | 0 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 152.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.21 | 52 Week High | $108.63 | |||
| Open | $152.21 | 52 Week Low | $71.39 | |||
| Day High | $152.21 | P/E | 84.09 | |||
| Day Low | $152.21 | EPS | $1.81 | |||
| Volume | 3,013 | |||||
